CAPR Logo

Capricor Therapeutics, Inc. (CAPR) 

NASDAQ$12.22
Market Cap
$555.64M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
39 of 924
Rank in Industry
29 of 527

CAPR Insider Trading Activity

CAPR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$14,999,9981100
Sells
$000

Related Transactions

Nippon Shinyaku Co Ltd10 percent owner1$15M0$0$15M

About Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company â€¦

Insider Activity of Capricor Therapeutics, Inc.

Over the last 12 months, insiders at Capricor Therapeutics, Inc. have bought $15M and sold $0 worth of Capricor Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Capricor Therapeutics, Inc. have bought $5.02M and sold $474.71M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Nippon Shinyaku Co Ltd (10 percent owner) — $15M.

The last purchase of 2,798,507 shares for transaction amount of $15M was made by Nippon Shinyaku Co Ltd (10 percent owner) on 2024‑09‑20.

List of Insider Buy and Sell Transactions, Capricor Therapeutics, Inc.

2024-09-20PurchaseNippon Shinyaku Co Ltd10 percent owner
2.8M
9.1284%
$5.36$15M+195.20%
2023-10-12PurchaseMusket David Bdirector
410
0.0015%
$2.75$1,128+63.96%
2023-10-10PurchaseCOLLIER EARL M JRdirector
10,000
0.0395%
$2.83$28,300+62.63%
2023-10-09PurchaseMusket David Bdirector
5,083
0.02%
$2.82$14,334+66.01%
2023-10-06PurchaseAuwaerter Paul Gisbertdirector
5,000
0.019%
$2.84$14,200+58.45%
2023-10-04PurchaseMusket David Bdirector
2,500
0.0095%
$2.90$7,250+61.62%
2023-04-17SaleAvat Xavier
14,772
–
$64,258.00$949.22M+3.61%
2023-03-28SaleAvat Xavier
3,000
0.0118%
$4.06$12,180+6.46%
2022-06-29SaleMusket David B
28,215
0.1163%
$3.77$106,371+19.68%
2022-06-29PurchaseAvat XavierCHIEF BUSINESS OFFICER
1,500
0.0062%
$3.76$5,643+19.68%
2022-06-27SaleMusket David B
17,775
0.0736%
$4.44$78,921+1.59%
2017-05-09PurchaseCEDARS SINAI MEDICAL CENTER10 percent owner
2.29M
11.0606%
$3.10$7.1M-46.21%
2017-05-09PurchaseManzo Louisdirector
20,000
0.0966%
$3.10$62,000-46.21%
2017-05-09PurchaseMusket David Bdirector
50,000
0.2415%
$3.10$155,000-46.21%
2016-09-21PurchaseCEDARS SINAI MEDICAL CENTER10 percent owner
625,000
3.0673%
$3.20$2M-26.89%
2016-03-16PurchaseCEDARS SINAI MEDICAL CENTER10 percent owner
833,332
4.8375%
$2.40$2M+29.40%
2016-03-16PurchaseGRASMICK LOUIS Jdirector
182,738
1.0608%
$2.40$438,571+29.40%
2016-03-16PurchaseSt. John Edward A.10 percent owner
833,332
4.8375%
$2.40$2M+29.40%
2016-03-16PurchaseMarban LindaChief Executive Officer
30,456
0.1768%
$2.40$73,094+29.40%
2016-03-16PurchaseManzo Louisdirector
200,000
1.161%
$2.40$480,000+29.40%
Total: 65
*Gray background shows transactions not older than one year

Insider Historical Profitability

24.11%
Nippon Shinyaku Co Ltd10 percent owner
7090351
15.5935%
$86.64M10
CEDARS SINAI MEDICAL CENTER10 percent owner
4049959
8.9069%
$49.49M40+25.52%
Marban Eduardo10 percent owner
3173354
6.979%
$38.78M20<0.0001%
KASH PETER Mdirector
1596208
3.5105%
$19.51M30
TANEN DAVID Mdirector
1520705
3.3444%
$18.58M40
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$36,510,315
95
8.95%
$611.9M
$587,109,125
90
3.17%
$524.24M
$14,527,743
76
38.40%
$495.98M
$678,065,999
37
-13.32%
$608.58M
$94,912,877
34
-7.15%
$601.56M

CAPR Institutional Investors: Active Positions

Increased Positions85+119.72%11M+133.35%
Decreased Positions32-45.07%2M-21.85%
New Positions51New5MNew
Sold Out Positions17Sold Out1MSold Out
Total Postitions124+74.65%17M+111.5%

CAPR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$39,252.006.59%2.97M+1M+69.54%2024-12-31
Vanguard Group Inc$30,122.005.06%2.28M+700,243+44.42%2024-12-31
Farallon Capital Management Llc$29,773.005%2.25M+2MNew2024-12-31
State Street Corp$29,217.004.91%2.21M+2M+331.06%2024-12-31
Geode Capital Management, Llc$11,635.001.95%879,468+241,279+37.81%2024-12-31
Altium Capital Management Llc$9,446.001.59%714,000+429,000+150.53%2024-12-31
Morgan Stanley$8,358.001.4%631,754+500,238+380.36%2024-12-31
Woodline Partners Lp$8,334.001.4%629,934+629,934New2024-12-31
Northern Trust Corp$5,082.000.85%384,157+116,086+43.3%2024-12-31
Goldman Sachs Group Inc$3,900.000.66%294,768+216,504+276.63%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.